Biopsy is the surgical removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissue. Biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. Conventional biopsy devices can be complemented with advanced imaging technologies such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others to perform a biopsy procedure with accuracy and minimal invasiveness. These integrated procedures are important to perform biopsies in critical areas of the body such as the lungs, liver, and kidney.
Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements have been stimulating the growth of the biopsy devices market. Moreover, increase in awareness for the diagnosis of chronic diseases such as breast cancer and lung cancer is also increasing the demand for integrated biopsy technologies such as MRI-guided biopsy. On the contrary, the use of advanced biopsy devices in developing countries is still restricted due to high cost, unawareness for the diagnosis of chronic diseases, and lack of technical expertise. However, companies are now concentrating on developing cost-effective biopsy devices, which would decrease the overall cost of biopsy procedures.
The report segments the world biopsy devices market by device type, application, biopsy procedures, imaging technologies, end users, and geography. The types of devices profiled in this report include breast biopsy devices, gastrointestinal (GI) biopsy devices, soft tissue biopsy devices, bronchial biopsy devices, gynaecological biopsy devices, robotic biopsy devices, and other devices. Based on application, the report is segmented into breast biopsy, gastrointestinal (GI) biopsy, prostate, liver, lung, kidney, gynaecological, and others. End users for the biopsy devices market comprise hospitals and diagnostic centers. Geographically, the world biopsy devices market is segmented across North America, Europe, Asia-Pacific, and LAMEA.
Product launches was the most preferred strategy followed by collaborations & geographic expansion for market capitalization. The report provides a comprehensive analysis of the leading companies operating in the world biopsy devices market. The key companies profiled in the report are C.R. Bard, Inc., Leica Biosystems, Hologic, Inc., Becton, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Mauna Kea Technologies, Cook Medical, Inc., Medtronic, Argon Medical Devices, Inc, Intact Medical Corp., and others.
KEY BENEFITS FOR STAKEHOLDERS:
This report provides an extensive analysis of the current and emerging trends and dynamics in the world biopsy devices market.
The report provides a detailed analysis of the current market and estimations from 2014 to 2022, which would enable the stakeholders to capitalize on the prevailing opportunities.
The biopsy devices market scenario is comprehensively analyzed in accordance to key geographical regions.
The key players are profiled in the report, and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Competitive intelligence highlights the business practices followed by leading market players across geographies.
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
BIOPSY DEVICES MARKET KEY SEGMENTS:
By Device Type
Breast biopsy devices
Gastrointestinal (GI) biopsy devices
Soft tissue biopsy devices
Bronchial biopsy devices
Gynaecological biopsy devices
Robotic biopsy devices
Other devices (brushes, punches, and curettes)
Gastrointestinal (GI) biopsy
Others (thyroid, pancreas, and gall bladder)
By Imaging Technology
Others (positron emission tomography, X-ray, and sonography)
By End User